Polyphor POL7080 And The Journey to The Land of Pyocyanea (Part 1)
![](https://i0.wp.com/allphasepharma.com/dir/wp-content/uploads/2015/10/bridge-Pyocyanea-copy.jpg?resize=640%2C180&ssl=1)
When Roche inlicensed Polyphor’s anti-pseudomonas drug POL7080 in November 2013, it marked a turning point. It seemed that Big Pharma that had all but abandoned the field in the last decade and was getting engaged in anti-infectives again. When a Continue reading Polyphor POL7080 And The Journey to The Land of Pyocyanea (Part 1)